-+ 0.00%
-+ 0.00%
-+ 0.00%

*Arcturus Therapeutics: Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0 Next-Generation mRNA Delivery Platform

Dow Jones·09/23/2026 20:06:00

请登录查看新闻详情